GLP-1 RAs are prescribed to about 20% of potentially eligible adolescents, with increasing odds based on several individual factors.
The Pan American Health Organization delays a review of US measles elimination status to “simplify and standardize the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results